E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/30/2004 in the Prospect News Convertibles Daily and Prospect News High Yield Daily.

S&P: Matria Healthcare unaffected

Standard & Poor's said Tuesday that the ratings and outlook on Matria Healthcare Inc. (B+/stable/--), a provider of disease-state management and related products, would not be affected by the company's tender offer for its 11% senior unsecured notes nor by the company's lowered earnings per share guidance for the first quarter of 2004.

Matria has not disclosed how it will finance the tender for about $120 million of its unsecured notes. However, the company has stated that it expects to save more than $5 million of net interest annually from the transaction.

While viewed positively by S&P, the agency said these savings are not significant enough to alter the ratings or outlook on the company.

Matria also announced that it is lowering its earnings guidance for the first quarter of 2004 to a range of 8 to 12 cents per share from 14 to 19 cents per share because of a revenue shortfall in the women's health segment. This has no bearing on the ratings, as S&P had already anticipated potential operating difficulties in this segment and reflected them in its opinion.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.